Tracking the Prevalence and Incidence of Modifiable Suicide Risk Factors During the COVID‑19 Pandemic to Inform Targeted Suicide Prevention in British Columbia
COVID-19 Variant Supplement – Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19
Development, implementation, and evaluation of equitable and effective e-mental health care delivery for parents and care givers struggling with anxiety and depression arising during the COVID‑19 pandemic: improving access and matching services to need.